TGRX-326 Chinese Phase II for Advanced Non-small Cell Lung Cancer (NSCLC)

Swipe the table sideways for more columns.

Trial	Conditions	Status	Phase	Updated	More info	NCT ID
TGRX-326 Chinese Phase II for Advanced Non-small Cell Lung Cancer (NSCLC)	Neoplasms by Site, Thoracic Neoplasms, bronchial neoplasm, bronchogenic carcinoma, lung disorder, lung neoplasm, neoplasm, non-small cell lung carcinoma, respiratory system disorder, respiratory tract neoplasm	Active, not recruiting	Phase 2	2025-05-18		NCT05955391

36 results · Page 1 of 2

Swipe the table sideways for more columns.

Organizations	Linked trials
Affiliated Cancer Hospital of Guizhou Medical University	3
Bingzhou Medical University Affiliated Hospital	1
Cancer Hospital Chinese Academy of Medical Science, Shenzhen Center	23
Capital Medical School Beijing Chest Hospital	1
First Affiliated Hospital of Zhejiang University	201
First Affiliated Hospital Xi'an Jiaotong University	142
First Affiliated Hospital, Sun Yat-Sen University	113
First Hospital of China Medical University	92
Fujian Cancer Hospital	114
Haerbin Medical University Cancer Hospital	1
Henan Cancer Hospital	147
Hunan Cancer Hospital	66
Jiangxi Provincial Cancer Hospital	33
Jilin Provincial Tumor Hospital	8
Jingzhou First People's Hospital	2
Liaoning Cancer Hospital & Institute	53
Mianyang Central Hospital	12
Nanchang University First Affiliated Hospital	1
Ningbo No. 1 Hospital	31
Shandong Cancer Hospital and Institute	71
Shanghai Chest Hospital	116
Shenzhen TargetRx Co., Ltd.	9
Shijiazhuang People's Hospital	9
Sichuan Cancer Hospital and Research Institute	64
Sun Yat-Sen University Cancer Center	74

1 results · Page 1 of 1

Swipe the table sideways for more columns.

Research sites	City	Country	Linked trials
Sun Yat-sen University Cancer Center	Guangzhou	China	315

Clinical trials